an.zamora
TL2 · Kaunas
Contributes reviews on supplier material. Based in Kaunas.
Joined 21 November 2024 · last posted 5d · groups: translators
86 posts, newest first. Showing up to 150.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #57 · Compounds › Secretagogues & GH axis · 23 Jul 2026 · 30 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #20 · Clinical › Bloodwork · 17 Jul 2026 · 1 like The arithmetic in post #17 is right; the assumption feeding it is the part to check. Glycaemic markers integrate over different periods. A point glucose and a…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #70 · Compounds › Retatrutide · 17 Jul 2026 · 7 likes The reason retatrutide discussion keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
An 18-month record including the parts that went badly Replied, post #68 · Outcomes › Progress reports · 13 Jul 2026 · 2 likes Confirming post #66 from a second method, which matters more than confirming it from a second person. Medication changes: escalating dose, or adding or removing other…
-
What is genuinely unknown about long-term amylin agonism Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 12 Jul 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Immortal time bias in a claims-database study — one year on Replied, post #7 · Evidence › Study critique · 4 Jul 2026 · 2 likes The arithmetic on Immortal time bias is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Micro-titration: a disputed topic, argued properly Replied, post #88 · Practice › Dosing & titration · 12 Jun 2026 · 1 like Adding what did not work for me on micro-titration, since the failures never get written up and they are half the useful information.
-
Micronutrient adequacy at low total intake Replied, post #13 · Nutrition & Training › Protein & intake · 6 Jun 2026 · 20 likes This follows post #12 rather than contradicting it. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight.…
-
Reading a trial's population section before its results Replied, post #86 · Evidence › Trials · 4 Jun 2026 · 20 likes This settles it for me, at least until somebody posts a reason it should not.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #42 · Access › Insurance & coverage · 2 Jun 2026 · 0 likes A peer-to-peer review is available in many systems and is frequently more productive than a written appeal, because it is a conversation with somebody who can decide.
-
Reading a trial's population section before its results Replied, post #65 · Evidence › Trials · 29 May 2026 · 0 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #24 · Evidence › Trials · 12 May 2026 · 14 likes Posting my Primary endpoint hierarchies numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who…
-
Reimbursement variation across member states Replied, post #6 · Regional › European Union · 3 May 2026 · 6 likes Post #5 is right about the mechanism and I think understates the practical bit. France: ANSM implements EU framework. Reimbursement has been narrower for weight…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #56 · Devices › Syringes & needles · 24 Apr 2026 · 20 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. I looked…
-
Micro-titration: a disputed topic, argued properly Replied, post #63 · Practice › Dosing & titration · 21 Apr 2026 · 0 likes The failure mode on micro-titration is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get…
-
Coming back to: Time to steady state after a dose increase Replied, post #36 · Pharmacology › Pharmacokinetics · 20 Apr 2026 · 0 likes Where I part company with post #34, and it is a narrow parting. Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than…
-
Reading a home test result without over-claiming Replied, post #5 · Analytics › Home & field testing · 4 Apr 2026 · 2 likes Noted, and thank you for writing it out rather than summarising it.
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #96 · Regional › UK & Ireland · 29 Mar 2026 · 1 like Adding the measurement that post #95 says would settle it. Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #11 · Pharmacology › Formulation chemistry · 27 Mar 2026 · 0 likes On Solubility limits: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #72 · Practice › Storage & stability · 24 Mar 2026 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #43 · Practice › Interactions · 8 Mar 2026 · 11 likes Anaesthesia and elective surgery came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #83 · Practice › Storage & stability · 27 Feb 2026 · 21 likes Confirming post #82 from a second method, which matters more than confirming it from a second person. Clarity is a weak test. A solution can lose a significant fraction…
-
When a dose reduction is the correct response to a side effect — a second dataset Replied, post #7 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
-
Measurement error in home scales, with a worked standard deviation Replied, post #7 · marked as the solution · Research Methods › Statistics · 14 Feb 2026 · 7 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #7 · marked as the solution · Compounds › Semaglutide · 24 Jan 2026 · 10 likes Answering the question post #3 raises rather than the one it answers. Injection site does not appear to matter much for semaglutide exposure. The published comparisons…
-
Travelling with an injectable: documentation and practicalities Replied, post #7 · Access › International · 23 Jan 2026 · 17 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page. This is the sort…
-
Dead volume across syringe and needle combinations Replied, post #55 · Devices › Syringes & needles · 15 Jan 2026 · 8 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Blinding yourself: practical methods and their limits Started this topic · Research Methods › N-of-1 designs · 15 Jan 2026 · 13 likes On the subject in the title: Blinding yourself: practical methods and their limits Working notes rather than a conclusion. A methods question rather than a substantive…
-
Adolescents: a distinct evidence base — one year on Replied, post #51 · Clinical › Special populations · 6 Jan 2026 · 2 likes The claim about Adolescents upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #40 · Practice › Side effects · 27 Dec 2025 · 28 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #15 · Meta › Site feedback · 7 Dec 2025 · 0 likes This follows post #14 rather than contradicting it. Feedback on the trust-level page: it explains what each level unlocks, and not what a member at that level is…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #18 · Start Here › Welcome · 7 Dec 2025 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] What a good consultation looks like from the other side Replied, post #6 · Clinical › Prescriber conversations · 5 Dec 2025 · 9 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.
-
Temperature loggers worth the money — the long version Replied, post #85 · Devices › Cold chain · 2 Dec 2025 · 0 likes Confirming post #82 from a second method, which matters more than confirming it from a second person. An update on my earlier Temperature loggers worth the money post:…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #57 · Clinical › Special populations · 26 Nov 2025 · 0 likes Building on post #55 rather than restating it. Summarising the Older adults thread so far, since it is long and the answer is buried: the first reply has the method,…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #75 · Start Here › How to Ask · 25 Oct 2025 · 15 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #74 · Compounds › Tirzepatide · 22 Oct 2025 · 8 likes Taking post #71 at face value and following it one step further. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction —…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #5 · Compounds › Oral incretins · 13 Oct 2025 · 19 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #44 · Compounds › Tirzepatide · 23 Sep 2025 · 24 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #62 · Practice › Reconstitution · 18 Sep 2025 · 0 likes I had written a reply contradicting post #58 and deleted it. Here is what survived. Summarising the decimal-point error thread so far, since it is long and the answer…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #34 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes Independent test results are the most valuable data this community collects, and they are only comparable when the method is captured alongside the number. Not a strong…
-
Titles that describe the question, not the situation Replied, post #88 · Start Here › How to Ask · 4 Sep 2025 · 15 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
A preprint whose numbers changed substantially at publication Replied, post #25 · Evidence › Preprints · 20 Aug 2025 · 5 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #31 · Compounds › Repair & healing peptides · 16 Aug 2025 · 28 likes Post #30 is right about the mechanism and I think understates the practical bit. Adding a small correction to the BPC-157 summary above rather than a disagreement with…
-
Travel coolers and how long they really hold Replied, post #68 · Devices › Cold chain · 6 Aug 2025 · 0 likes Customs holds are the most common cause of an unexpectedly long transit, and they are also the segment nobody has visibility of. Tracking gaps are usually that rather…
-
A request that was declined, and the reasoning — a second dataset Replied, post #5 · Documentation › Wiki requests · 5 Aug 2025 · 13 likes Requests for a document covering something the evidence does not support get declined, and the decline usually points at what could be written instead. Happy to be…
-
Documentation that appears only after payment Started this topic · Sourcing › Red flags · 4 Aug 2025 · 14 likes Documentation that appears only after payment Writing it up because I had to work it out twice and would rather nobody else did. Proposing that documentation deserves a…
-
How to research a compound with no human data without deceiving yourself Replied, post #86 · Compounds › Other compounds · 3 Aug 2025 · 13 likes Anything in this subcategory with a published trial behind it should be discussed separately from anything without one. Mixing them produces a discussion where the…
-
How to research a compound with no human data without deceiving yourself Replied, post #65 · Compounds › Other compounds · 2 Aug 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
EU-wide position versus national implementation Replied, post #21 · Regional › European Union · 28 Jul 2025 · 4 likes I disagree with the framing of eu-wide position versus national implementation above, and I think it is a substantive disagreement rather than a terminological one.…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #2 · Practice › Storage & stability · 19 Jul 2025 · 27 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I am reporting…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #6 · Analytics › COA interpretation · 12 Jul 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #23 · Documentation › Doc review · 9 Jul 2025 · 17 likes Post #20 is the version of this I will quote in future. One addition. For anyone finding this later: the short answer on Promotion criteria is that it depends on one…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #83 · Compounds › Tirzepatide · 6 Jul 2025 · 0 likes Post #81 put the caveat in the right place and I want to underline it. Checked the GIP component of tirzepatide claim against the primary source this morning. It…
-
Antibiotics and a course of something with delayed emptying Replied, post #73 · Practice › Interactions · 24 Jun 2025 · 1 like Following this. I have the same question and no better information than the first post.
-
A supplier that answers analytical questions with restated claims Replied, post #101 · Sourcing › Red flags · 20 Jun 2025 · 1 like Post #99 put the caveat in the right place and I want to underline it. Nothing here should be read as an accusation against a named company, and the guidelines exist so…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #123 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 21 likes A request rather than an answer: could whoever has the primary source for CagriSema phase 2 paper post it? I have seen the claim three times this month and each version…
-
Meeting a protein target on a suppressed appetite Replied, post #5 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 8 likes That matches what I have seen, for whatever a single anecdote is worth.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #87 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 17 likes My position on CagriSema phase 2 paper is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #68 · Compounds › Tirzepatide · 9 Jun 2025 · 6 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #24 · Analytics › Home & field testing · 8 Jun 2025 · 0 likes The documentation on quantitation is better than this thread and I say that as someone who has posted in the thread.
-
Half-life, steady state, and accumulation worked through Replied, post #6 · Pharmacology › Pharmacokinetics · 20 May 2025 · 13 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
-
UK access routes, dated and sourced — a second dataset Replied, post #79 · Regional › UK & Ireland · 17 May 2025 · 13 likes Post #76 describes the usual case. This is about the unusual one. Correcting an out-of-date claim in this subcategory with a source and a date is more valuable than a…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #77 · Practice › Interactions · 8 May 2025 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #107 · Evidence › Journal club · 30 Apr 2025 · 16 likes Narrowing post #104, because the general version has more than one answer. Posting my SURMOUNT-1 numbers with the method attached so they can be discounted properly.…
-
Reading order for a first week here, and what to skip until later Replied, post #94 · Start Here › Welcome · 21 Apr 2025 · 18 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Adjudicated events and why the definition matters — the long version Replied, post #101 · Evidence › Trials · 16 Apr 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Adjudicated events and why the definition matters — the long version Replied, post #96 · Evidence › Trials · 13 Apr 2025 · 10 likes I had written a reply contradicting post #92 and deleted it. Here is what survived. The figure that circulates in coverage is almost always whichever estimand gives the…
-
A certificate with no method stated: what can you conclude? Replied, post #56 · Analytics › COA interpretation · 10 Apr 2025 · 0 likes Answering the question post #52 raises rather than the one it answers. A certificate is a statement by its issuer that a defined test was performed on a defined lot and…
-
Review cadence: how often is a page actually re-checked? Replied, post #8 · Documentation › Doc review · 4 Apr 2025 · 0 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here. Stating my…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #92 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 0 likes What I would tell a new member reading about cagrilintide alone for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
[2026 update] New subcategory: rationale and scope Replied, post #144 · Meta › Announcements · 13 Jan 2025 · 0 likes Everything in post #140 holds. The case it does not cover is the one I have. The number people quote for New subcategory is a central estimate presented without its…
-
A vial that will not fully dissolve: what to check and in what order Replied, post #9 · Practice › Reconstitution · 7 Jan 2025 · 0 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
-
Gallbladder disease risk with rapid weight loss Replied, post #52 · Clinical › Comorbidities · 3 Jan 2025 · 4 likes Where I would push back on the gallbladder disease risk consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #31 · Safety › Adverse events · 21 Dec 2024 · 1 like Adding a small correction to the Persistent vomiting summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
-
Building a sensible monitoring schedule with your prescriber Replied, post #51 · Clinical › Bloodwork · 20 Dec 2024 · 20 likes Narrowing post #48, because the general version has more than one answer. Building a sensible monitoring schedule: I would want to see the raw numbers rather than the…
-
What we do not know about retatrutide, listed explicitly Replied, post #26 · Compounds › Retatrutide · 19 Dec 2024 · 11 likes Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by definition, is not approved for human use, and carries no assurance…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #113 · Practice › Dosing & titration · 27 Nov 2024 · 6 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
[2026 update] How to read a forest plot, properly, from scratch Started this topic · Evidence › Trials · 23 Nov 2024 · 0 likes How to read a forest plot, properly, from scratch — that is the question, and I have not found it answered plainly anywhere I have looked. Reading SURMOUNT-4 ( JAMA ,…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #53 · Compounds › Repair & healing peptides · 14 Nov 2024 · 0 likes Answering the question post #51 raises rather than the one it answers. The absence of human trials means there is no established dose, no established interval and no…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #17 · Compounds › Other compounds · 10 Nov 2024 · 33 likes My experience of Research-use-only status contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
Revisiting: Moderation log format change Replied, post #8 · Meta › Announcements · 27 Oct 2024 · 0 likes Adding the measurement that post #5 says would settle it. The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is…
-
Progressive overload when the scale is falling — one year on Replied, post #44 · Nutrition & Training › Resistance training · 10 Sep 2024 · 8 likes A methods point on Progressive overload rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #14 · Practice › Interactions · 9 Sep 2024 · 25 likes Coming back to post #12, because the follow-up matters more than the original answer. Oral contraceptives and delayed emptying is a good example of a question where the…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #68 · Analytics › COA interpretation · 13 Aug 2024 · 0 likes Two questions I would want answered before drawing anything from the Purity assay versus content assay data above: how were the cases selected, and what happened to the…
-
Cold packs, phase-change material, and what survives ten days Replied, post #29 · Sourcing › Logistics · 20 Jun 2024 · 4 likes I would rather this thread reach "we do not know" about cold packs than reach a confident answer that nobody can support when asked.